ACAD

ACADIA PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.15

EPS Forecast

$251

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31

Proximilar's AI forecasts

EPS Forecast:

$0.15

Revenue Forecast:

$251

EPS Surprise Forecast:

$0.019

Revenue Surprise Forecast:

$2

Post-release price volatility - High

Post-release Overnight Move:

±9.8%

Post-release 1-week Move:

Odds of beating consensus

Probability of beating EPS consensus:

Probability of beating revenue consensus:

Probability of beating both EPS & revs consensus:

Probability of missing both EPS & revs consensus:

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

Beta (β)

Forward Looking Beta (β):

Earnings volatility

EPS standard deviation:

Revenue standard deviation:

Confidence intervals and percentiles

EPS 95th %ile:

Revenue 95th %ile:

$265

EPS 75th %ile:

$0.19

Revenue 75th %ile:

EPS 25th %ile:

$0.12

Revenue 25th %ile:

EPS 5th %ile:

Revenue 5th %ile:

$239

Stock's bid-ask spread

Bid-ask per $10K:

Bid-ask per Share: